ReNeuron wins orphan status for stem cell therapy – PMLiVE
|
ReNeuron wins orphan status for stem cell therapy
PMLiVE ReNeuron’s investigational stem cell therapy has received orphan status in the EU and US for use in a rare eye disorder. Both the European Medicines Agency (EMA) and the Food and Drug Administration (FDA) determined that ReN003 had the potential to … ReNeuron gets ‘orphan drug’ statusScotsman |
